The Future of Pediatric Care: Moving Beyond Silos with Integrated, Value-Based Models For too long, the healthcare journey for children with complex medical and behavioral needs has been fragmented. Parents often find themselves as the sole coordinators of care, navigating a maze of specialists, therapies and school support systems. This unsustainable model not only burdens … Read more
The CDC Director Search: A Sign of Shifting Priorities in Public Health? The search for a permanent director at the Centers for Disease Control and Prevention (CDC) is proving to be a complex undertaking. With President Trump struggling to find a suitable candidate, the role is currently held on an acting basis by Dr. Jay … Read more
The Future of Medicare: Automatic Enrollment and the Rise of Managed Care The debate over the future of Medicare is intensifying, with a potential shift towards automatic enrollment in Medicare Advantage plans gaining traction. Chris Klomp, President Trump’s Medicare director, recently revealed that the Centers for Medicare & Medicaid Services (CMS) is exploring the feasibility … Read more
Nursing Home Antipsychotic Misuse: A Looming Crisis and Potential Reforms Federal watchdog reports released this week underscore a persistent and troubling issue within the nursing home industry: the misuse of antipsychotic drugs and the inappropriate diagnosis of schizophrenia in residents with dementia. While not a new revelation, the latest findings from the Department of Health … Read more
The Rising Tide of Cancer Drug Costs: Beyond Price Negotiation For decades, the United States has grappled with the highest prescription drug prices globally, a burden acutely felt by cancer patients. The term “financial toxicity,” coined nearly two decades ago to describe the debilitating financial side effects of cancer treatment, remains tragically relevant. While recent … Read more
Medicare Drug Price Battles: What Trump’s Plans Mean for Your Wallet The pharmaceutical industry is bracing for potential showdowns with the Trump administration over proposals designed to lower Medicare drug costs. These plans, centered around aligning U.S. Prices with those paid in other developed nations, could dramatically reshape the landscape of prescription drug affordability. But … Read more
Medicare Advantage Growth Slows: What’s Behind the Shift? For years, Medicare Advantage (MA) plans have been the fastest-growing part of Medicare. But new data reveals a significant slowdown. As of February 1, enrollment reached 35.5 million, a modest 3% increase from the previous year. This marks a stark contrast to the 7%-10% annual growth seen … Read more
The Rising Tide of Scrutiny: Healthcare Fraud, Ethnic Targeting, and Political Clashes The recent controversy surrounding Dr. Mehmet Oz’s allegations of hospice fraud in Los Angeles, and the subsequent demand for a civil rights investigation by California Governor Gavin Newsom, isn’t an isolated incident. It’s a symptom of several converging trends: increased scrutiny of healthcare … Read more
The Billion-Dollar Bet on Medicaid Work Requirements: A Glimpse into Healthcare’s Future The recent announcement of $600 million in vendor discounts to states implementing Medicaid work requirements isn’t just a policy shift; it’s a powerful signal about where the healthcare industry sees future revenue. It suggests a growing market for technology solutions designed to manage … Read more
The Shifting Landscape of Inpatient Admissions: A Look Ahead The start of 2026 is already signaling a significant shift in how inpatient admissions are handled, and surprisingly, a major insurance company, UnitedHealthcare (UHC), is leading the charge. This isn’t about generosity; it’s about navigating a complex new reality created by the Centers for Medicare & … Read more